Robert Stewart
CEO, Theramex
The fight for women’s healthcare continues, as both GPs and women themselves clamour for information.
With a declining take up of HRT after the flawed WHI study, hormone related products were left to gather dust. Research stalled, companies even discontinued products. Theramex rescued crucial HRT products and fixed supply issues to once again provide GPs with a variety of menopause products.
But this isn’t enough for CEO Robert Stewart, he wants women to know that they have choices as they age, and that their GP will support them. He says, “I’m so proud of our team not just for getting our HRT products relaunched, but also to keep in focus the huge need for education on women’s health issues.
We know that with patients who are better informed, we can expect better outcomes.
Ensuring the best outcomes
“We know that with patients who are better informed, we can expect better outcomes. This is why we’re working with initiatives to help both GPs and patients better learn about the myriad of conditions a woman can face.”
For Stewart, the challenge is not just getting the message out, but tackling the chronic underfunding challenges which has left menopause care a postcode lottery. Still, he is optimistic. “There’s much more awareness now than a few years ago, but it’s clear there’s more to be done. And we want to help.”
Read more from women’s health experts
THX_003003 Mar 21
